Breaking News, Promotions & Moves

Astellas Pharma Europe

Ken Jones has been appointed president and chief executive officer of Astellas Pharma Europe Ltd. (APEL), the European subsidiary Astellas Pharma, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ken Jones has been appointed president and chief executive officer of Astellas Pharma Europe Ltd. (APEL), the European subsidiary Astellas Pharma, Inc. Mr. Jones previously served as chief operating officer of APEL, since July 2007. He succeeds Masao Yoshida, who has been appointed president and chief executive officer of Astellas Pharma US, Inc., the U.S. subsidiary of Astellas Pharma Inc. Mr. Jones, commented: “I am delighted and honored to be taking on this new role and I look forwar...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters